US6635676B2
(en)
*
|
1999-04-28 |
2003-10-21 |
Regents Of The University Of Michigan |
Non-toxic antimicrobial compositions and methods of use
|
US6506803B1
(en)
*
|
1999-04-28 |
2003-01-14 |
Regents Of The University Of Michigan |
Methods of preventing and treating microbial infections
|
US7767216B2
(en)
*
|
1999-04-28 |
2010-08-03 |
The Regents Of The University Of Michigan |
Antimicrobial compositions and methods of use
|
US7655252B2
(en)
*
|
1999-04-28 |
2010-02-02 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
US8232320B2
(en)
*
|
1999-04-28 |
2012-07-31 |
The Regents Of The University Of Michigan |
Antimicrobial nanoemulsion compositions and methods
|
DE60036952T2
(de)
*
|
1999-09-24 |
2008-08-07 |
Glaxosmithkline Biologicals S.A. |
Influenzavirus-impfstoffzusammensetzung zur nasalen anwendung
|
US6794352B2
(en)
|
2000-06-12 |
2004-09-21 |
Jeffrey S. Svendsen |
Cleaning towel having a color identifying label and sanitizer release polymer composition
|
AU2002367976B2
(en)
*
|
2001-06-05 |
2007-06-21 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
JP2010209109A
(ja)
*
|
2001-06-25 |
2010-09-24 |
Regents Of The Univ Of Michigan |
抗微生物ナノエマルジョンの組成物および方法
|
BR0212163A
(pt)
*
|
2001-08-28 |
2004-12-07 |
Eden Reseaech Plc |
Composição para tratamento ou prevenção de infecção em plantas
|
US7745686B2
(en)
|
2001-11-02 |
2010-06-29 |
Playtex Products, Inc. |
Catamenial device
|
US7799968B2
(en)
*
|
2001-12-21 |
2010-09-21 |
Kimberly-Clark Worldwide, Inc. |
Sponge-like pad comprising paper layers and method of manufacture
|
US20030175318A1
(en)
*
|
2002-03-06 |
2003-09-18 |
Schilling Amanda S. |
Application of germination solution improved efficacy of biological decontamination
|
WO2003086073A1
(en)
*
|
2002-04-17 |
2003-10-23 |
Agribiotec S.R.L. |
Use of vegetable oil as an adjuvant for substances having a fungicide, bactericide, insecticide and herbicide activity
|
GB0213097D0
(en)
|
2002-06-07 |
2002-07-17 |
Autoglym |
Improvements in or relating to organic matter
|
US20040111817A1
(en)
*
|
2002-12-17 |
2004-06-17 |
Kimberly-Clark Worldwide, Inc. |
Disposable scrubbing product
|
US7994079B2
(en)
*
|
2002-12-17 |
2011-08-09 |
Kimberly-Clark Worldwide, Inc. |
Meltblown scrubbing product
|
MXPA05009507A
(es)
|
2003-03-05 |
2006-03-10 |
Byocoat Entpr Inc |
Solucion y proceso antimicrobianos.
|
WO2005002337A1
(en)
*
|
2003-04-02 |
2005-01-13 |
Virtual Drug Development, Inc. |
Disinfectant compositions and methods
|
US20040204496A1
(en)
*
|
2003-04-11 |
2004-10-14 |
Ammon Daniel M. |
Disinfecting solutions effective against bacterial endospores
|
CA2528095C
(en)
*
|
2003-06-04 |
2014-10-14 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositions, and methods of use thereof
|
US20050208083A1
(en)
*
|
2003-06-04 |
2005-09-22 |
Nanobio Corporation |
Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
|
US7348097B2
(en)
*
|
2003-06-17 |
2008-03-25 |
Medtronic, Inc. |
Insulative feed through assembly for electrochemical devices
|
ATE378038T1
(de)
*
|
2003-07-07 |
2007-11-15 |
Nares Ab |
Mikroemulsionen und ihre verwendung zur prävention von erkrankungen der atemwege
|
US8211448B2
(en)
|
2003-07-07 |
2012-07-03 |
Nares Ab |
Microemulsions and its use for preventing airway diseases
|
US20050100601A1
(en)
*
|
2003-11-07 |
2005-05-12 |
Viratox, L.L.C. |
Virucidal activities of cetylpyridinium chloride
|
US20090232748A1
(en)
*
|
2003-11-07 |
2009-09-17 |
Viratox, L.L.C. |
Virucidal activities of cetylpyridinium chloride
|
EP1686993B1
(en)
*
|
2003-11-07 |
2011-01-12 |
Viratox, L.L.C. |
Virucidal activities of a composition comprising cetylpyridinium chloride and citric acid
|
US20050130536A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Disposable scrubbing product
|
US20050129897A1
(en)
*
|
2003-12-11 |
2005-06-16 |
Kimberly-Clark Worldwide, Inc. |
Disposable scrubbing product
|
US20050136772A1
(en)
*
|
2003-12-23 |
2005-06-23 |
Kimberly-Clark Worldwide, Inc. |
Composite structures containing tissue webs and other nonwovens
|
ES2921427T3
(es)
|
2004-01-23 |
2022-08-25 |
Eden Research Plc |
Métodos de eliminación de nematodos que comprenden la aplicación de un componente terpénico encapsulado
|
US7707931B2
(en)
|
2004-04-06 |
2010-05-04 |
West Liberty Foods, L.L.C. |
Clean room food processing systems, methods and structures
|
CN1997446B
(zh)
*
|
2004-05-20 |
2012-01-04 |
伊顿研究有限公司 |
含有包封萜成分的中空葡聚糖颗粒或细胞壁颗粒的组合物、其制备和使用方法
|
US20050260138A1
(en)
*
|
2004-05-21 |
2005-11-24 |
Virgil Flanigan |
Producton and use of a gaseous vapor disinfectant
|
NZ534007A
(en)
|
2004-07-09 |
2007-06-29 |
Horticulture & Food Res Inst |
Fungicidal composition comprising anhydrous milk fat (AMF) and soybean oil for the treatment of Powdery Mildew
|
US20060135026A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Kimberly-Clark Worldwide, Inc. |
Composite cleaning products having shape resilient layer
|
CA2600054A1
(en)
*
|
2005-03-09 |
2006-09-21 |
Combe Incorporated |
Stable mixed emulsions
|
WO2006110699A1
(en)
*
|
2005-04-11 |
2006-10-19 |
Nanobio Corporation |
Quaternary ammonium halides for treatment of infectious conditions
|
US20060292248A1
(en)
*
|
2005-06-20 |
2006-12-28 |
Bio-Germ Protection, Llc |
Biological attack protection kit and method
|
US20070015738A1
(en)
*
|
2005-07-15 |
2007-01-18 |
Walker Stephen G |
Use of non-antibacterial tetracycline formulations for inhibiting bacterial spores from becoming infectious vegetative cells
|
WO2008051186A2
(en)
|
2005-08-09 |
2008-05-02 |
Nanobio Corporation |
Nanoemulsion containing compositions having ant i -inflammatory activity
|
CN101316516B
(zh)
*
|
2005-09-03 |
2012-05-30 |
拜奥科特企业有限公司 |
抗菌溶液及其相关方法
|
US20070065390A1
(en)
*
|
2005-09-19 |
2007-03-22 |
Eric Spengler |
Stable emulsion systems with high salt tolerance
|
EP1954130B1
(en)
|
2005-11-30 |
2018-06-13 |
Eden Research Plc |
Methods comprising terpene mixtures comprising thymol and citral
|
AU2006321415B2
(en)
|
2005-11-30 |
2012-11-08 |
Cornell University |
Terpene-containing compositions and methods of making and using them
|
AR060043A1
(es)
*
|
2006-03-23 |
2008-05-21 |
Smithkline Beecham Corp |
Formulacion de limpieza de dispositivos dentales, metodo de limpieza de un dispositivo dental fuera de la cavidad bucal, estuche o conjunto (kit) para suministrar dicha formulacion, metodo para prevenir el aliento de dentadura y metodo para mantener el aliento fresco en la boca de un usuario de disp
|
US10138279B2
(en)
|
2006-04-13 |
2018-11-27 |
Regents Of The University Of Michigan |
Compositions and methods for Bacillus anthracis vaccination
|
US20080038295A1
(en)
*
|
2006-04-13 |
2008-02-14 |
Regents Of The University Of Michigan |
Compositions and methods for orthopox virus vaccination
|
US9839685B2
(en)
*
|
2006-04-13 |
2017-12-12 |
The Regents Of The University Of Michigan |
Methods of inducing human immunodeficiency virus-specific immune responses in a host comprising nasally administering compositions comprising a naonemulsion and recombinant GP120 immunogen
|
WO2008103416A1
(en)
*
|
2007-02-21 |
2008-08-28 |
Capps Charles L |
Synergistic enhancement of calcium propionate
|
CN101032507B
(zh)
*
|
2007-04-06 |
2010-09-29 |
西北农林科技大学 |
一种红霉素纳米乳抗菌药物及其制备方法
|
WO2008137747A1
(en)
|
2007-05-02 |
2008-11-13 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
CN102083415A
(zh)
*
|
2008-04-18 |
2011-06-01 |
纳米生物公司 |
用于治疗疱疹病毒感染的方法
|
EP2278997B1
(en)
*
|
2008-04-21 |
2016-08-10 |
Nanobio Corporation |
Nanoemulsion influenza vaccine
|
AU2009240389A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Nanobio Corporation |
Nanoemulsions for treating fungal, yeast and mold infections
|
US20090269394A1
(en)
*
|
2008-04-25 |
2009-10-29 |
Nanobio Corporation |
Methods and compositions for treating onchomycosis
|
US20090291095A1
(en)
*
|
2008-05-23 |
2009-11-26 |
The Regents Of The University Of Michigan |
Nanoemulsion adjuvants
|
CA2725329C
(en)
|
2008-05-23 |
2013-10-01 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
FR2933104B1
(fr)
*
|
2008-06-26 |
2015-10-09 |
Biomerieux Sa |
Milieu de culture comportant un compose inhibiteur ou retardateur de germination de spores
|
WO2010036945A2
(en)
|
2008-09-26 |
2010-04-01 |
The Regents Of The University Of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
CA2738630A1
(en)
|
2008-10-10 |
2010-04-15 |
Dara Biosciences, Inc. |
Methods for treating or preventing pain using spicamycin derivatives
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
EP2369923B1
(en)
*
|
2008-11-26 |
2016-06-22 |
Viroblock SA |
Methods for inhibiting gram-positive bacteria using non-phospholipid lipid vesicules
|
CA2750233A1
(en)
|
2009-01-28 |
2010-08-05 |
Nanobio Corporation |
Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof
|
US8668911B2
(en)
|
2009-05-14 |
2014-03-11 |
The Regents Of The University Of Michigan |
Streptococcus vaccine compositions and methods of using the same
|
MY159500A
(en)
|
2009-05-22 |
2017-01-13 |
Genocea Biosciences Inc |
Vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
EP2442827B1
(en)
|
2009-06-16 |
2016-01-06 |
The Regents of the University of Michigan |
Nanoemulsion vaccines
|
US20110135702A1
(en)
*
|
2009-12-09 |
2011-06-09 |
Hoffman Douglas R |
Sporicidal composition for clostridium difficile spores
|
US20110200683A1
(en)
*
|
2010-02-16 |
2011-08-18 |
Piper Medical, Inc |
Hydrogen peroxide solution producing first aid substance, packaging, and treatment
|
US20110229516A1
(en)
*
|
2010-03-18 |
2011-09-22 |
The Clorox Company |
Adjuvant phase inversion concentrated nanoemulsion compositions
|
WO2011116262A2
(en)
*
|
2010-03-19 |
2011-09-22 |
The Regents Of The University Of Michigan |
Compositions and methods for diagnosing and treating urinary tract infections
|
EP2571383B1
(en)
|
2010-05-20 |
2022-01-26 |
Ecolab USA Inc. |
Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
|
JP2014520805A
(ja)
|
2011-07-06 |
2014-08-25 |
ナノバイオ コーポレーション |
ヒト呼吸器合胞体ウイルスワクチン
|
EP2747779A4
(en)
|
2011-08-22 |
2015-04-08 |
Nanobio Corp |
VACCINE AGAINST HERPES SIMPLEX VIRUS IN THE FORM OF NANOEMULSION
|
BR112014005406A2
(pt)
|
2011-09-09 |
2017-03-28 |
Nanobio Corp |
composição de vacina e respectivo uso
|
WO2013078299A1
(en)
|
2011-11-23 |
2013-05-30 |
Genocea Biosciences, Inc. |
Nucleic acid vaccines against herpes simplex virus type 2: compositions and methods for eliciting an immune response
|
CN102526139A
(zh)
*
|
2012-02-23 |
2012-07-04 |
华子昂 |
一种人工阴道液及其制备方法
|
FR2997304B1
(fr)
*
|
2012-10-26 |
2017-07-07 |
Isp Investments Inc |
Utilisation d’un extrait de lin, en tant qu’agent actif activateur de la synthese de peptides antimicrobiens
|
GB201220940D0
(en)
|
2012-11-21 |
2013-01-02 |
Eden Research Plc |
Method P
|
CN103830726A
(zh)
*
|
2012-11-23 |
2014-06-04 |
魏维 |
抗微生物有机纳米组合物及其制备方法
|
KR20140141857A
(ko)
*
|
2013-05-31 |
2014-12-11 |
한국생명공학연구원 |
패실로마이세스 속 균주를 이용한 생물 농약 제조방법
|
JP7158853B2
(ja)
|
2014-10-10 |
2022-10-24 |
ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン |
対象における食物アレルギーまたは呼吸器アレルギーを処置するための、かつ上記対象の鼻腔内に投与するための免疫原性組成物
|
DK3289076T3
(da)
|
2015-05-01 |
2022-01-17 |
Prec Biosciences Inc |
Præcis sletning af kromosomale sekvenser in vivo
|
WO2017007835A1
(en)
|
2015-07-07 |
2017-01-12 |
Nanobio Corporation |
Methods and compositions for nanoemulsion vaccine formulations
|
US10603363B2
(en)
|
2015-09-08 |
2020-03-31 |
Precision Biosciences, Inc. |
Treatment of retinitis pigmentosa using engineered meganucleases
|
ES2803728T3
(es)
|
2015-10-05 |
2021-01-29 |
Prec Biosciences Inc |
Células genéticamente modificadas que comprenden un gen de región constante alfa del receptor de linfocitos T humano modificado
|
WO2017062439A1
(en)
|
2015-10-05 |
2017-04-13 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human t cell receptor alpha constant region gene
|
EP3988655A3
(en)
|
2015-12-23 |
2022-08-03 |
Precision Biosciences, Inc. |
Engineered meganucleases with recognition sequences found in the human beta-2 microglobulin gene
|
NZ745936A
(en)
|
2016-04-27 |
2020-02-28 |
Univ Puerto Rico |
1,5-disubstituted 1,2,3-triazoles are inhibitors of rac/cdc42 gtpases
|
EP3452583B1
(en)
|
2016-05-03 |
2021-10-27 |
Precision Biosciences, Inc. |
Engineered nucleases useful for treatment of hemophilia a
|
WO2017201390A1
(en)
|
2016-05-19 |
2017-11-23 |
The Regents Of The University Of Michigan |
Novel adjuvant compositions
|
JP6897031B2
(ja)
*
|
2016-09-01 |
2021-06-30 |
住友ベークライト株式会社 |
防カビ剤、防カビ樹脂フィルム、防カビ積層フィルム及び防カビ包装体
|
WO2018064232A1
(en)
|
2016-09-28 |
2018-04-05 |
Genocea Biosciences, Inc. |
Methods and compositions for treating herpes
|
AU2017338846B2
(en)
|
2016-10-04 |
2020-09-24 |
Precision Biosciences, Inc. |
Co-stimulatory domains for use in genetically-modified cells
|
SG10201914029RA
(en)
|
2016-10-14 |
2020-03-30 |
Precision Biosciences Inc |
Engineered meganucleases specific for recognition sequences in the hepatitis b virus genome
|
WO2018073393A2
(en)
|
2016-10-19 |
2018-04-26 |
Cellectis |
Tal-effector nuclease (talen) -modified allogenic cells suitable for therapy
|
MX2019012452A
(es)
|
2017-04-21 |
2020-08-03 |
Prec Biosciences Inc |
Meganucleasas diseñadas especificas para secuencias de reconocimiento en el gen pcsk9.
|
EP3615662A1
(en)
|
2017-04-28 |
2020-03-04 |
Precision Biosciences, Inc. |
Methods for reducing dna-induced cytotoxicity and enhancing gene editing in primary cells
|
CA3062698A1
(en)
|
2017-05-08 |
2018-11-15 |
Precision Biosciences, Inc. |
Nucleic acid molecules encoding an engineered antigen receptor and an inhibitory nucleic acid molecule and methods of use thereof
|
AU2018292526A1
(en)
|
2017-06-30 |
2020-01-16 |
Precision Biosciences, Inc. |
Genetically-modified T cells comprising a modified intron in the T cell receptor alpha gene
|
EP3684436A1
(en)
|
2017-09-22 |
2020-07-29 |
Becton, Dickinson and Company |
4% trisodium citrate solution for use as a catheter lock solution
|
EP3692057B9
(en)
|
2017-10-03 |
2023-10-04 |
Precision BioSciences, Inc. |
Modified epidermal growth factor receptor peptides for use in genetically-modified cells
|
EP3704238B1
(en)
|
2017-11-01 |
2024-01-03 |
Precision Biosciences, Inc. |
Engineered nucleases that target human and canine factor viii genes as a treatment for hemophilia a
|
ES2955408T3
(es)
|
2018-04-12 |
2023-11-30 |
Prec Biosciences Inc |
Nucleasas modificadas genéticamente optimizadas que tienen especificidad para el gen de la región constante alfa del receptor de linfocitos t humanos
|
US11142750B2
(en)
|
2018-04-12 |
2021-10-12 |
Precision Biosciences, Inc. |
Optimized engineered meganucleases having specificity for a recognition sequence in the Hepatitis B virus genome
|
US11369578B2
(en)
|
2018-11-15 |
2022-06-28 |
Bluewillow Biologics, Inc. |
Persistent topical antimicrobial compositions and methods of using the same
|
JP2022507451A
(ja)
|
2018-11-15 |
2022-01-18 |
ブルーウィロー バイオロジクス、インコーポレイテッド |
強化された透過性を有するナノエマルジョン組成物
|
EP3898661A1
(en)
|
2018-12-21 |
2021-10-27 |
Precision BioSciences, Inc. |
Genetic modification of the hydroxyacid oxidase 1 gene for treatment of primary hyperoxaluria
|
CN109845757A
(zh)
*
|
2019-03-15 |
2019-06-07 |
威海市农业科学院 |
果园用病虫害铲除剂及其制备方法、使用方法
|
EP4332115A2
(en)
|
2019-04-03 |
2024-03-06 |
Precision Biosciences, Inc. |
Genetically-modified immune cells comprising a microrna-adapted shrna (shrnamir)
|
US20220273715A1
(en)
|
2019-07-25 |
2022-09-01 |
Precision Biosciences, Inc. |
Compositions and methods for sequential stacking of nucleic acid sequences into a genomic locus
|
JP2022544825A
(ja)
|
2019-08-20 |
2022-10-21 |
プレシジョン バイオサイエンシズ,インク. |
細胞免疫療法のためのリンパ球枯渇投与レジメン
|
WO2021075391A1
(ja)
|
2019-10-17 |
2021-04-22 |
タマ化学工業株式会社 |
除菌組成物及びそれを用いる細菌芽胞の除菌方法
|
WO2021087305A1
(en)
|
2019-10-30 |
2021-05-06 |
Precision Biosciences, Inc. |
Cd20 chimeric antigen receptors and methods of use for immunotherapy
|
EP4069285A1
(en)
|
2019-12-06 |
2022-10-12 |
Precision BioSciences, Inc. |
Methods for cancer immunotherapy, using lymphodepletion regimens and cd19, cd20 or bcma allogeneic car t cells
|
CN116057068A
(zh)
|
2019-12-06 |
2023-05-02 |
精密生物科学公司 |
对乙型肝炎病毒基因组中的识别序列具有特异性的优化的工程化大范围核酸酶
|
CN111110631A
(zh)
*
|
2020-03-20 |
2020-05-08 |
苏国霞 |
一种高效广谱的抗菌纳米乳及其制备方法
|
WO2021231259A1
(en)
|
2020-05-11 |
2021-11-18 |
Precision Biosciences, Inc. |
Self-limiting viral vectors encoding nucleases
|
WO2021231495A1
(en)
|
2020-05-12 |
2021-11-18 |
Precision Biosciences, Inc. |
Treatment of retinitis pigmentosa using improved engineered meganucleases
|
WO2022035793A1
(en)
|
2020-08-10 |
2022-02-17 |
Precision Biosciences, Inc. |
Antibodies and fragments specific for b-cell maturation antigen and uses thereof
|
AU2021329403A1
(en)
|
2020-08-21 |
2023-05-04 |
Precision Biosciences, Inc. |
Engineered meganucleases having specificity for a recognition sequence in the transthyretin gene
|
EP4244342A1
(en)
|
2020-11-12 |
2023-09-20 |
Precision BioSciences, Inc. |
Engineered meganucleases having specificity for recognition sequences in the dystrophin gene
|
EP4274889A1
(en)
|
2021-01-08 |
2023-11-15 |
Precision BioSciences, Inc. |
Engineered meganucleases having specificity for a recognition sequence in the hydroxyacid oxidase 1 gene
|
EP4284823A1
(en)
|
2021-01-28 |
2023-12-06 |
Precision BioSciences, Inc. |
Modulation of tgf beta signaling in genetically-modified eukaryotic cells
|
JP2024517655A
(ja)
|
2021-04-22 |
2024-04-23 |
プレシジョン バイオサイエンシズ,インク. |
ヒトのミトコンドリアゲノムを標的とする操作されたメガヌクレアーゼ
|
CA3173245A1
(en)
|
2021-04-22 |
2022-10-22 |
James Jefferson Smith |
Engineered meganucleases that target human mitochondrial genomes
|
CA3235185A1
(en)
|
2021-10-19 |
2023-04-27 |
Cassandra GORSUCH |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
WO2023070002A2
(en)
|
2021-10-19 |
2023-04-27 |
Precision Biosciences, Inc. |
Gene editing methods for treating alpha-1 antitrypsin (aat) deficiency
|
WO2023081767A1
(en)
|
2021-11-05 |
2023-05-11 |
Precision Biosciences, Inc. |
Methods for immunotherapy
|